. . World News – United States – Boeing stock-rating raised (NYSE: BA) by Robert W.. Bird

Subscribe to MarketBeat All Access to access MarketBeat’s full suite of search tools:

The Boeing (NYSE: BA) airliner was upgraded by stock researchers at Robert W.. . Byrd was rated « Outperforming » in a report released on Wednesday, reports Stock Target Advisors. The brokerage currently has $ 306. 00 Price target on aircraft product inventory. Robert W.. Bird price target indicates a potential high of 45. 68% of the company’s current price.

Other analysts recently released research reports on the stock. Alembic Global Advisors upgraded Boeing shares from « neutral » to « overweight » and raised company target price from $ 150. 00 to $ 184. 00 in a research report on Monday, September 28. CSFB boosted its price target for The Boeing shares from $ 154. 00 to $ 184. 00 and gave the company a « neutral » rating in a research note on Tuesday, 6 October. Morgan Stanley lowered his price target on The Boeing shares from $ 181. 00 to $ 165. 00 and a « underweight » rating of the stock was placed in a research note on Thursday, October 29th. Goldman Sachs Group reaffirmed its « buy » rating and identified $ 214. 00 Price Target on Boeing Shares in a Research Note on Thursday, October 29th. Finally, UBS Group is $ 150. 00 price target on Boeing stocks and the company awarded a « neutral » rating in a research note on Wednesday, November 4th. Five research analysts rated the stock a sell rating, thirteen issued a hold rating, eleven analysts issued a buy rating and one issued a strong buy rating for the company. The stock had a consensus rating of « Hold » and a unanimous target price of $ 208. 04. (adsbygoogle = window. adsbygoogle || (]). push ({});

Boeing shares opened at $ 210. 05 on Wednesday. Boeing has a 52-week low of $ 89. 00 and a 52-week high at $ 375. 60. The company has a 50-day moving average of $ 165. 63 and 200 days at a moving average of $ 165. 85. The company has a market cap of $ 118. 58 billion, P / E-26. 62 and a beta of 1. 39.

Boeing (NYSE: BA) released its latest quarterly earnings data on Wednesday, October 28. Aircraft producer reported ($ 1. 39) Earnings per share for the quarter, exceeding the consensus estimate of $ 2. 33) is reduced by $ 0. 94. Boeing had a negative net margin of 7. 34% negative return on equity 3. 08%. As a group, analysts predict that Boeing will deploy the -9. 22 earnings per share for the current year.

Several institutional investors and hedge funds have recently bought and sold shares of the Library of Alexandria. Neo Ivy Capital Management bought a new stake in The Boeing Company during the third quarter for $ 25,000. Magnolia Capital Advisors LLC purchased a new stake in The Boeing during the third quarter worth nearly $ 26,000. Tortoise Investment Management LLC increased its stake in Boeing by 83. 3% in the third quarter. Tortoise Investment Management LLC now owns 165 aircraft maker shares worth $ 27,000 after purchasing an additional 75 shares in the last quarter.. . Professional Financial Advisors LLC bought a new position in The Boeing shares in the third quarter for approximately $ 31,000. Finally, Hall Laurie J Trustee bought a new third-quarter position in The Boeing stock for approximately $ 33,000.. 52. 57% of the shares are currently owned by institutional investors.

Boeing, along with its subsidiaries, designs, develops, manufactures, sells, services and supports commercial aircraft, military aircraft, satellites, missile defense, human spaceflight, launch systems and services around the world. The company operates through four sectors: Commercial Airplanes. & Security and Defense; Global services; And Boeing Capital.

This instant news alert was created by narrative science technology and financial data from MarketBeat to provide readers with the fastest and most accurate reports.. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to [email protected]

October 2, 2020, may not be categorized as one of the « Where were you when » moments. But when the news broke that the president of the United States and the first lady had tested positive for the new coronavirus, there was definitely a feeling that we were living in a historic moment (as if we weren’t really there).

During the following days, several biotech and pharmaceutical companies made headlines. However, it was not these vaccine stocks that investors had committed to storing in memory. These companies were leading the race for antiviral treatments.

And with all the evidence so prominent for the concept, the treatment may have had a moment. It’s too early to tell if these drugs really hold the answer. But since the start of the epidemic, it has been felt that treatments may hold the ultimate solution to neutralize the most severe effects of the new Coronavirus. .

As you might expect, there is no shortage of companies in remedial discussion. In this special presentation, we highlight seven companies you should pay close attention to. If treatments move in before a vaccine, these stocks are likely to lead to strong upward moves.

Complete the form below to receive the latest headlines and analyst recommendations on your stocks through our free daily email newsletter:

Subscribe to MarketBeat All Access to access MarketBeat’s complete search toolkit:

View the latest news, buy / sell valuations, SEC deposits and insider transactions for your stocks. Compare your portfolio performance against leading indices and get personalized stock ideas based on your portfolio.

Get daily stock ideas from top performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. See the most active stocks on social media with MarketBeat’s Hot Stock Report.

Select stocks that meet your criteria with seven unique stock sorters. Find out what’s happening in the market right now with MarketBeat’s real-time news feed. Export data to Excel for your own analysis.

Looking for new stock ideas? Want to see which stocks are moving? View our full collection of financial calendars and market spreadsheets, all for free.

Get free global investment education from MarketBeat. Learn about financial terms, types of investments, trading strategies, and more.

MarketBeat enables individual investors to make better trading decisions by providing real-time financial data and objective market analysis.. Whether you are looking for analyst assessments, company buybacks, dividends, dividends, economic or financial reports, insider deals, IPOs, SEC filings, or stock splits, MarketBeat has the objective information. You need to analyze any stock. I know more.

© American Consumer News, LLC dba MarketBeat® 2010-2020. All rights reserved.
326 E 8th St # 105, Sioux Falls, SD 57103 | [Email protected] | (844) 978-6257
MarketBeat does not provide financial advice nor does it issue recommendations or offers to buy shares or sell any security. I know more.
Don’t sell my information

© 2020 Market Data provided at least 10 minutes delayed and hosted by Barchart Solutions. Fundamental company data provided by Morningstar and Zacks Investment Research. The information is provided « as is » and for informational purposes only, and not for commercial or advice purposes, and is delayed. For all exchange delays and terms of use, please see our disclaimer.

Enter your email address below to receive a brief daily summary of analyst promotions, rating cuts and new coverage with MarketBeat. Free daily email newsletter.

NYSE: BA, Boeing, General Electric, Stock, NYSE: GE